Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,555 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Time course in the development of cerebral vasospasm after experimental subarachnoid hemorrhage: clinical and neuroradiological assessment of the rat double hemorrhage model.
Vatter H, Weidauer S, Konczalla J, Dettmann E, Zimmermann M, Raabe A, Preibisch C, Zanella FE, Seifert V. Vatter H, et al. Among authors: zimmermann m. Neurosurgery. 2006 Jun;58(6):1190-7; discussion 1190-7. doi: 10.1227/01.NEU.0000199346.74649.66. Neurosurgery. 2006. PMID: 16723899
Robot-assisted navigated neuroendoscopy.
Zimmermann M, Krishnan R, Raabe A, Seifert V. Zimmermann M, et al. Neurosurgery. 2002 Dec;51(6):1446-51; discussion 1451-2. Neurosurgery. 2002. PMID: 12445350
Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist clinically effective for the treatment of cerebral vasospasm. Part I: inhibitory effect on endothelin(A) receptor-mediated contraction.
Vatter H, Zimmermann M, Tesanovic V, Raabe A, Schilling L, Seifert V. Vatter H, et al. Among authors: zimmermann m. J Neurosurg. 2005 Jun;102(6):1101-7. doi: 10.3171/jns.2005.102.6.1101. J Neurosurg. 2005. PMID: 16028770
Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist shown to be clinically effective for the treatment of cerebral vasospasm. Part II: effect on endothelin(B) receptor-mediated relaxation.
Vatter H, Zimmermann M, Tesanovic V, Raabe A, Seifert V, Schilling L. Vatter H, et al. Among authors: zimmermann m. J Neurosurg. 2005 Jun;102(6):1108-14. doi: 10.3171/jns.2005.102.6.1108. J Neurosurg. 2005. PMID: 16028771
2,555 results